Literature DB >> 27108191

Effect of introduction of pentavalent vaccine as replacement for Diphtheria-Tetanus-Pertussis and Hepatitis B vaccines on vaccination uptake in a health facility in Nigeria.

Ayebo Evawere Sadoh1, Damian Uchechukwu Nwaneri2, Bamidele Charity Ogboghodo2, Wilson Ehidiamen Sadoh3.   

Abstract

BACKGROUND: The introduction of a new vaccine into an immunization programme may affect the immunization system negatively or positively. The aim of this study is to determine the effect of the introduction of the pentavalent vaccine as replacement for DTP and Hepatitis B vaccines on timeliness, completion of the schedule and dropout rates among children attending a health facility.
METHODOLOGY: This was a retrospective cohort study which involved extracting immunization records of children attending the Institute of Child Health Child Welfare Clinic between June 2011 and May 2013. Pentavalent vaccine was introduced as a replacement for DTP and Hepatitis B vaccines in June 2012. The uptake, timeliness and dropout rates of different vaccines in the immunization schedule were determined for children who commenced immunization in the pre, peri and post introduction phases.
RESULTS: A total of 1110 children were studied - 190, 410 and 510 who commenced vaccination in the pre, peri and post introduction phases of the pentavalent vaccine respectively. Uptake was significantly higher for all vaccines in the post introduction phase compared to pre and peri introduction phases (p<0.001). Completion of the immunization schedule by 60.2% of the children who commenced vaccination in the post introduction phase was higher than the 31.6% and 41.7% for the pre and peri introduction phases respectively (p<0.001). Significantly more visits were required to complete the schedule in the peri introduction phase compared to the pre and post introduction phases p<0.001. Delay in receipt of the three doses of DTP/PENTA was significantly longer in the peri introduction phase compared to pre and post introduction phases.
CONCLUSION: The introduction of pentavalent vaccine significantly improved uptake of vaccines and completion of the schedule but resulted in prolonged delay in receipt of vaccines during the introduction period.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Effect; Immunization; Introduction; Pentavalent; Uptake; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 27108191     DOI: 10.1016/j.vaccine.2016.04.026

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective.

Authors:  Alejandro Ramirez Gonzalez; Margaret Farrell; Lisa Menning; Julie Garon; Hans Everts; Lee M Hampton; Samantha B Dolan; Stephanie Shendale; Sarah Wanyoike; Chantal Laroche Veira; Gaël Maufras du Châtellier; Feyrouz Kurji; Jennifer Rubin; Liliane Boualam; Diana Chang Blanc; Manish Patel
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

2.  Vaccination timeliness and delay in low- and middle-income countries: a systematic review of the literature, 2007-2017.

Authors:  Nina B Masters; Abram L Wagner; Matthew L Boulton
Journal:  Hum Vaccin Immunother       Date:  2019-06-12       Impact factor: 3.452

3.  Implementation and adherence of routine pertussis vaccination (DTP) in a low-resource urban birth cohort.

Authors:  Christian E Gunning; Lawrence Mwananyanda; William B MacLeod; Magdalene Mwale; Donald M Thea; Rachel C Pieciak; Pejman Rohani; Christopher J Gill
Journal:  BMJ Open       Date:  2020-12-31       Impact factor: 3.006

4.  Impact of state weights on national vaccination coverage estimates from household surveys in Nigeria.

Authors:  Tracy Qi Dong; Dale A Rhoda; Laina D Mercer
Journal:  Vaccine       Date:  2020-06-10       Impact factor: 3.641

5.  Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine.

Authors:  Beckie N Tagbo; Rowan E Bancroft; Iretiola Fajolu; Mohammed B Abdulkadir; Muhammad F Bashir; Olusola P Okunola; Ayodeji H Isiaka; Namadi M Lawal; Benedict O Edelu; Ngozi Onyejiaka; Chinonyerem J Ihuoma; Florence Ndu; Uchenna C Ozumba; Frances Udeinya; Folasade Ogunsola; Aishat O Saka; Abayomi Fadeyi; Sunday A Aderibigbe; Jimoh Abdulraheem; Adamu G Yusuf; Peter Sylvanus Ndow; Philomena Ogbogu; Chinomnso Kanu; Velly Emina; Olajumoke J Makinwa; Florian Gehre; Kabir Yusuf; Fiona Braka; Jason M Mwenda; Johnson M Ticha; Dorothy Nwodo; Archibald Worwui; Joseph N Biey; Brenda A Kwambana-Adams; Martin Antonio
Journal:  Clin Infect Dis       Date:  2019-09-05       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.